跳至主要内容
临床试验/NCT01335217
NCT01335217已完成1 期

Trigeminal Nerve Stimulation for PTSD and Depression

University of California, Los Angeles2 个研究点 分布在 1 个国家目标入组 20 人开始时间: 2011年1月最近更新:
适应症

试验速览

阶段
1 期
状态
已完成
入组人数
20
试验地点
2
主要终点
Change in Hamilton Depression Rating Scale-17 Item

研究概览

简要总结

This is a 20-subject, dose finding study to examine the use of external trigeminal nerve stimulation (TNS) as an adjunctive treatment for adults with major depressive disorder (MDD) co- occurring with posttraumatic stress disorder (PTSD) when added onto antidepressant medications. Our primary objective is the examination of TNS in this patient population.

To accomplish our specific aims, the investigators will test the following specific hypotheses:

  1. Subjects will show improvement in ratings of mood, PTSD, and other symptoms during the eight-week period.
  2. Subjects will show improvement in ratings of life functional capacity and quality of life with TNS.
  3. Subjects will report the TNS treatments to be acceptable in terms of side effects and burden of using the device.

详细描述

A total of 20 subjects with Major Depressive Disorder (MDD) co-occurring with Post Traumatic Stress Disorder (PTSD), ages 18 to 75 years, will be consented and join this project at UCLA.

The project will use TNS in under open-label conditions, using the same stimulation parameters as have been used in prior studies in MDD by itself and in treatment-refractory epilepsy. Subjects will be seen every two weeks during the 8 week study. At the end of the 8 weeks, the TNS systems will be returned and the adjunctive treatment will end. The co-primary endpoints are the changes in depression severity and in PTSD severity from enrollment to the week 8 visit.

研究设计

研究类型
Interventional
分配方式
Na
干预模型
Single Group
主要目的
Treatment
盲法
None

入排标准

年龄范围
18 Years 至 75 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • 未提供

排除标准

  • 未提供

结局指标

主要结局

Change in Hamilton Depression Rating Scale-17 Item

时间窗: Baseline, week 8

Change in PTSD Checklist score

时间窗: Baseline, Week 8

次要结局

  • Change in life functional capacity and quality of life scales(baseline, week 8)
  • Changes in vital signs recordings(At every visit for 8 weeks)
  • Changes in Safety Assessment Measures(At every visit for 8 weeks)

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Ian A. Cook, M.D.

Principal Investigator

University of California, Los Angeles

研究点 (2)

Loading locations...

相似试验